Connect with us

Cannabis News

White House Drug Czar And Principle Trump Advisor: Marijuana Legalization Is Up To Each State



  • Multiple officials in the White House are supportive of states making their own rules.
  • The drug czar is supposed to take an oppositional stance on legalizing any Schedule I controlled substance.

Marijuana legalization is sweeping across the country as each state determines exactly how to handle this substance. Based on the comments recently made by two of the top federal drug officials, it looks like this way of legalizing cannabis won’t change at all. Comments from the Office of National Drug Control Policy (ONDCP) indicate that the White House drug czar, as well as the drug officials, will leave the legalization of marijuana to the states.

The director of the drug policies of the Trump administration, Jim Carroll, spoke with reporter Kayla Sullivan of Fox 59 on the matter, saying that he believes that legalization is a states’ right issue. Furthermore, he hopes that educational campaigns will teach the public about the use of cannabis during pregnancy, the concerns about underage use, and impaired driving.

The federal law states that the drug czar (Carroll) is required to “take such actions as necessary to oppose any attempt to legalize the use of a substance” that is considered to be a Scheduled I controlled substance. In this case, Carroll would be required to oppose the legalization of marijuana, which he technically does at the federal level. However, at the state level, this policy appears to be a gray area for Carroll. Even if the comments don’t specifically violate the stipulation, the fact that he is proactive about state legalization is still significant.

A senior advisor with ONDCP, Anne Hazlett, spoke with on cannabis legalization, voicing the similar opinion that the legalization of marijuana is “a state decision.”

Hazlett stated,

“Marijuana is an ongoing challenge that is being addressed in many of our states. This is a state decision, and we would like to see additional research done so that these decisions being made at a state level are being made in manor that is fully informed.”

Even though these comments appear to show a refreshing perspective from the federal government on the prohibition at the state level, the director of the ONDCP has made comments in the past that he doesn’t have a positive outlook on the legal market. THC potency was a major concern that Carroll expressed at a House Committee on Oversight and Reform hearing three months ago.

Carroll commented that the current marijuana circulating through the market is “nothing like what it was when I was a kid, when I was in high school. Back then the THC, the ingredient in marijuana that makes you high, was in the teens in terms of the percentage. Now what we’re seeing is twice that, three times that, in the plant.”

He added that,

“The industry should introduce more research about marijuana. In the meantime, both the Drug Enforcement Administration and the Department of Health and Human Services are “working hard to make sure that we understand the impact of legalization of marijuana on the body.”

Make sure you check out our CBD state laws guide for more additional information as well as visiting this valuable resource for more reading.

Alex Ramsteen plugs his content writing microphone in all the way from Kenya and has been a professional writer for over a handful of year nearing a decade soon. While the skill of writing is apparent naturally, TOC is delighted to leverage Alex’s strengths into an array of interests including technology, science, fitness, yoga, meditation, traveling, electronics, reading and more.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.